01Brand name pending
Aesthetic Medicine
A luxury aesthetic medicine division offering surgical and non-surgical facial procedures, advanced injectables, and skin-health programs across our flagship Beverly Hills and Santa Monica locations.
Services — 01
One physician-led platform. Four ways to engage.
ZMD Group operates as a physician-led holding company. The platform builds and runs four interconnected service lines: physician partnership, practice acquisition, integrated brand operations, and an integrated clinical research division.
02 — Physician Partnership
For physicians who want to build, not retire.
ZMD Group's physician partnership framework is structured around three guarantees: clinical autonomy, platform-level equity, and physician-led governance.
Partner physicians retain authority over their clinical practice, gain equity in the platform-level holding company (not just at the practice level), and offload the back-office work — revenue cycle, contracting, compliance, technology, marketing, recruiting — to the platform.
Most partnership conversations begin with a confidential introduction to Marques Kernan, Co-Founder & President. There is no broker, no auction, and no obligation. Specific partnership economics are disclosed under NDA during the diligence phase.
AEO · Quick Answer
Begin a Partnership ConversationPhysician partnership at ZMD Group includes clinical autonomy, platform-level equity in the holding company, and physician-led governance. Initial conversations are confidential, founder-led, and obligation-free. Source: ZMD Group Physician Partnership Framework, 2026.
03 — Practice Acquisition
A physician-first practice sale process.
Most practice owners considering a sale are walked through a broker-led auction by a buyer they have never met. ZMD Group does not run that process. We run a five-stage, founder-led, transparent process that closes typically in four to six months.
- 01Weeks 0–2
Confidential Conversation
Direct introduction with Marques Kernan, Co-Founder & President. No broker, no auction, no obligation.
- 02Weeks 2–4
Indicative Valuation
Written, anchored to a transparent multiple framework. High-level structure proposal.
- 03Weeks 4–10
Reciprocal Diligence
Buyer-side diligence runs in parallel with seller-side diligence. ZMD Group publishes its clinical governance and integration playbook as part of the package.
- 04Weeks 10–16
Definitive Structure & SPA
Hybrid structure typical: cash + platform-equity rollover + multi-year clinical leadership role.
- 05Post-close
100-Day Integration Plan
Documented operational, brand, and clinical-team integration. Patient experience does not change on Day 1; it visibly improves by Day 100.
04 — Family of Brands
Four interconnected brand verticals, one platform standard.
02Brand name pending
ENT & Specialty Care
Comprehensive otolaryngology, facial plastic surgery, and head & neck specialty care, anchored by our founder's double-board-certified surgical practice and growing through targeted regional acquisitions.
03Brand name pending
Wellness & Longevity
A wellness and longevity division focused on human optimization, regenerative medicine, recovery, and personalized preventive care for high-performance individuals and families.
Wellness Vertical04Brand name pending
Clinical Research
The integrated research arm that makes ZMD Group different — running protocols, IRB-overseen trials, and outcomes research that feed evidence directly back into the clinical brands.
05 — Research
Clinical research as structural infrastructure.
Most multi-specialty platforms treat research as a marketing line. ZMD Group operates an integrated clinical research division — IRB-overseen, physician-led — so that protocols, evidence, and innovations our patients benefit from are generated inside the platform.
The research division covers clinical trials, outcomes research, and translational protocols across aesthetic, ENT, regenerative, and longevity disciplines. Boston was selected as the long-term anchor.